Home > News > Madison start-up seeks to shine at Mid-America Venture Forum
September 16th, 2007
Madison start-up seeks to shine at Mid-America Venture Forum
Abstract:
Jeff Williams will make his first-ever pitch to venture capitalists this month.
He'll be marketing a business with enormous potential that is operating at the intersection of biotech and nanotechnology.
Platypus Technologies has exclusive rights to 13 patents that cover the use of liquid crystals for sensors and other detection devices. The Madison company employs 18 peoplein its lab who have high-level expertise in engineering, molecular biology, physics and other disciplines.
Source:
jsonline.com
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Sensors
Tiny nanosheets, big leap: A new sensor detects ethanol at ultra-low levels January 30th, 2026
From sensors to smart systems: the rise of AI-driven photonic noses January 30th, 2026
Sensors innovations for smart lithium-based batteries: advancements, opportunities, and potential challenges August 8th, 2025
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Metasurfaces smooth light to boost magnetic sensing precision January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||